Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage-- Large Hemorrhage Evacuation (MIRACLE-L)
Recruiting
N/A
Interventional Study
Intracerebral Hemorrhage
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 550 (estimated)
- Sponsor
- Capital Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To determine if minimally invasive soft channel brain hemorrhage evacuation (scMIS), compared with any other neurosurgical technique that includes open craniotomy, small skull window microsurgery , and endoscopic surgery, is at least as effective ('not inferior') on poor clinical outcome of death or major disability (mRS scores 4-6) at 6 months in basal ganglia intracerebral hemorrhage (ICH) of 30…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
* Inclusion Criteria:
1. Adults (18 - 80 years) ;
2. The clinical diagnosis is acute intracerebral hemorrhage, confirmed by imaging;
3. Onset within 48 hours, and surgery can be initiated within 48 hours;
4. Basal ganglia hemorrhage, with a bleeding volume of 30 \< volume ≤ 100 ml;
5. Red…
Contacts